Byproducts of 'junk DNA' implicated in cancer spread

August 14, 2018, University of California - San Diego
UC San Diego biologists found that active enhancer RNAs (eRNAs) directly interact with BRD4, a protein linked to tumor development. Credit: Lauberth lab, UC San Diego

The more scientists explore so-called "junk" DNA, the less the label seems to fit.

Only an estimated two percent of the human genome encodes for functional proteins that carry out normal biological processes. The remaining approximately 98 percent—the "junk DNA"—has for many years been considered a useless artifact. Some junk DNA has been shown to be transcribed into RNA molecules that support cellular functions, including transfer RNAs (tRNAS) and microRNAs (miRNAs), while the remaining noncoding RNA has continued to be considered nonfunctional "junk" RNA.

Previous work by researchers at the University of California San Diego in Assistant Professor Shannon Lauberth's lab uncovered several thousand enhancer RNAs (eRNAs) that are robustly produced in in response to chronic immune signaling. eRNAs are a recently identified class of noncoding RNAs and their identification has begged the interesting question of whether they are functional in the cell. Now, members of the Lauberth team have revealed that eRNAs play a significant role in dissemination.

Publishing their results in Nature Structural and Molecular Biology, UC San Diego graduate student Homa Rahnamoun, Lauberth and their colleagues found that eRNAs have a direct role in the activation of that are important for tumor development. This eRNA role is facilitated by the ability of the eRNAs to directly interact with BRD4, a protein known as a cancer disseminator. BRD4 has been recognized as a promising target in cancer and several small molecules developed to act against BRD4 are under active clinical investigations.

"Our findings reveal that eRNAs are key regulators of cancer by acting to reinforce BRD4 binding and keep it anchored on DNA, which keeps the tumor-promoting genes turned on at high levels," said Lauberth. "Interestingly, when we deplete several of these eRNAs, we can significantly reduce the expression of the tumor-promoting genes that the eRNAs and BRD4 are co-regulating."

Now that we see that eRNAs impact BRD4 function, we have to rethink the way that we therapeutically target BRD4, Lauberth says.

"Taken together, our findings are consistent with the emerging notion that eRNAs are functional molecules, rather than merely reflections of enhancer activation or simply transcriptional noise... So this is going to transform the way that we think about 'junk RNA' and the regulation of gene expression in the context of the human cell."

Future studies in the Lauberth lab will explore mechanisms of eRNA synthesis and function in gene regulation and the methods necessary to target eRNAs in order to halt their cancer-promoting mechanisms.

Explore further: 'Mysterious' non-protein-coding RNAs play important roles in gene expression

More information: Homa Rahnamoun et al. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation, Nature Structural & Molecular Biology (2018). DOI: 10.1038/s41594-018-0102-0

Related Stories

'Mysterious' non-protein-coding RNAs play important roles in gene expression

January 12, 2017
In cells, DNA is transcribed into RNAs that provide the molecular recipe for cells to make proteins. Most of the genome is transcribed into RNA, but only a small proportion of RNAs are actually from the protein-coding regions ...

Enhancer RNAs alter gene expression: New class of molecules may be key emerging 'enhancer therapy'

June 4, 2013
(Medical Xpress)—In a pair of distinct but complementary papers, researchers at the University of California, San Diego School of Medicine and colleagues illuminate the functional importance of a relatively new class of ...

Mutant gene found to fuel cancer-promoting effects of inflammation

October 19, 2017
A human gene called p53, which is commonly known as the "guardian of the genome," is widely known to combat the formation and progression of tumors. Yet, mutant forms of p53 have been linked to more cases of human cancer ...

Study offers new insight into powerful inflammatory regulator

May 1, 2017
A new study in mice reveals how a protein called Brd4 boosts the inflammatory response—for better and for worse, depending on the ailment. The study is the first to show that this protein, while problematic in some circumstances, ...

Protein that switches cancers from inflammation to proliferation identified

February 5, 2016
Oxford University scientists researching PAD4, a protein that plays a role in the development of inflammatory diseases like arthritis and which is regularly found in cancers have uncovered the protein's role in cancer development. ...

Recommended for you

New findings cast light on lymphatic system, key player in human health

October 16, 2018
Scientists at the Oklahoma Medical Research Foundation have broken new ground in understanding how the lymphatic system works, potentially opening the door for future therapies.

Age-related increase in estrogen may cause common men's hernia

October 16, 2018
An age-related increase in estrogen may be the culprit behind inguinal hernias, a condition common among elderly men that often requires corrective surgery, according to a Northwestern Medicine study was published Oct. 15 ...

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Discovery of inner ear function may improve diagnosis of hearing impairment

October 15, 2018
Results from a research study published in Nature Communications show how the inner ear processes speech, something that has until now been unknown. The authors of the report include researchers from Linköping University, ...

Team's study reveals hidden lives of medical biomarkers

October 12, 2018
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.